Last reviewed · How we verify
NCT06769243: CogFlexTMS
Cognitive Flexibility and Response to TMS Therapy
NA trial testing TMS in Obsessive-Compulsive Disorder in 30 participants. Completed in 15 March 2024.
20 February 2024
Quick facts
| Lead sponsor | Gulhane Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 15 April 2023 |
| Primary completion | 20 February 2024 |
| Estimated completion | 15 March 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- TMS — full drug profile →
Conditions studied
- Obsessive-Compulsive Disorder — all drugs for Obsessive-Compulsive Disorder →
- Cognitive Flexiblity — all drugs for Cognitive Flexiblity →
Sponsor
Gulhane Training and Research Hospital
Who can join
Adults 18 to 65, any sex, with Obsessive-Compulsive Disorder or Cognitive Flexiblity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Transcranial Magnetic Stimulation (TMS) therapy is an approved and effective treatment option for treatment-resistant obsessive-compulsive disorder. The present study aims to investigate the relationship between cognitive flexibility and TMS treatment. The main question it aims to answer is: Does cognitive flexibility predict the TMS treatment response rate? Patients will undergo neuropsychological tests to evaluate cognitive flexibility before the TMS application. A clinical scale to assess the severity of obsessive-compulsive symptoms will be administered using psychometric scales both before and after the TMS procedure. TMS treatment will be applied five days a week for four weeks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06769243
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of TMS
Trials testing the same drug.
- NCT07346794 — The Underlying Neural Mechanism of TMS in Improving the Imbalance of "Microbiota-brain-gut Axis" in Alzheimer 's Disease · NA · not yet recruiting
- NCT07290738 — Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders · NA · recruiting
- NCT07010614 — Brain Stimulation to the Hippocampus in Schizophrenia · NA · recruiting
- NCT06274112 — Using TMS to Understand Neural Processes of Social Motivation · NA · recruiting
- NCT07147218 — Accelerated TMS for MDD · NA · recruiting
Other recruiting trials for Obsessive-Compulsive Disorder
Currently open trials in the same condition.
- NCT06575075 — Pilot Study of RR-HNK in OCD · Phase 1, PHASE2 · recruiting
- NCT05783817 — MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study) · Phase 2 · recruiting
- NCT07065669 — Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation · NA · recruiting
- NCT06376734 — Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness · Phase 2 · recruiting
- NCT07000812 — EEG Evaluation of CBT for Obsessive-Compulsive Disorder · NA · active not recruiting
Other Gulhane Training and Research Hospital trials
Trials by the same sponsor.
- NCT07283588 — İntensive Care Sepsis Prevelance in Turkey (INSEP-TURK) · active not recruiting
- NCT07145554 — f-ESWT vs Steroid Injection for Piriformis Syndrome · NA · completed
- NCT07039370 — Molecular Signatures of TMS Response in Treatment-Resistant Depression · NA · recruiting
- NCT06995222 — The Role of Renal Resistive Index (RI) in Predicting Acute Kidney Injury Progression in Intensive Care Clinic · recruiting
- NCT06765031 — The Role of Furosemide Stress Test in the Intensive Care Clinic · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06769243 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gulhane Training and Research Hospital
- Last refreshed: 10 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06769243.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing